Always Remember - Buy The Dip

Sentiment Analysis For CDNA

The news is currently generally neutral for CDNA.

Based on TextBlob analysis of Yahoo! Finance news summaries for CDNA on 2015-03-03.

Yahoo! Finance News for CDNA

DIAXONHIT Signs Service Sub-licensing Deal To Process CareDx AlloMap Tests
DIAXONHIT Signs Service Sub-licensing Deal To Process CareDx AlloMap Tests

US IPO Recap: Biotech Sage and adtech TubeMogul pop over 60% on first day
On Tuesday, the chair of the Federal Reserve warned that valuations in biotech stocks were stretched, which sparked a selloff across the sector. On Friday, the week's only biotech IPO, Sage Therapeutics ( SAGE ), spiked 67%

CareDx prices downsized IPO at $10, well below the range
CareDx, which sells molecular diagnostic tests to monitor heart transplants, raised $40 million in a downsized IPO by offering 4.0 million shares at $10, well below the range of $15 to $17. The company originally planned to

11 US IPOs planned for the week of Jul 14
The following IPOs are expected to price this week CareDx ( CDNA ), which sells molecular diagnostic tests to monitor heart transplants, plans to raise $50 million by offering 3.1 million shares at a price range

Heart transplant monitor company CareDx sets terms for $50 million IPO
CareDx, which sells molecular diagnostic tests to monitor heart transplants, announced terms for its IPO on Monday. The Brisbane, CA based company plans to raise $50 million by offering 3.1 million shares at a price range of